These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 16938571)
1. hCDC4 variation in osteosarcoma. Yan T; Wunder JS; Gokgoz N; Seto KK; Bell RS; Andrulis IL Cancer Genet Cytogenet; 2006 Sep; 169(2):138-42. PubMed ID: 16938571 [TBL] [Abstract][Full Text] [Related]
2. Inactivation of hCDC4 can cause chromosomal instability. Rajagopalan H; Jallepalli PV; Rago C; Velculescu VE; Kinzler KW; Vogelstein B; Lengauer C Nature; 2004 Mar; 428(6978):77-81. PubMed ID: 14999283 [TBL] [Abstract][Full Text] [Related]
3. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer. Kwak EL; Moberg KH; Wahrer DC; Quinn JE; Gilmore PM; Graham CA; Hariharan IK; Harkin DP; Haber DA; Bell DW Gynecol Oncol; 2005 Jul; 98(1):124-8. PubMed ID: 15913747 [TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the hCDC4 gene in gastric carcinomas. Lee JW; Soung YH; Kim HJ; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH Eur J Cancer; 2006 Sep; 42(14):2369-73. PubMed ID: 16824748 [TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125 [TBL] [Abstract][Full Text] [Related]
7. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer. Ekholm-Reed S; Spruck CH; Sangfelt O; van Drogen F; Mueller-Holzner E; Widschwendter M; Zetterberg A; Reed SI Cancer Res; 2004 Feb; 64(3):795-800. PubMed ID: 14871801 [TBL] [Abstract][Full Text] [Related]
8. The Fbxw7/hCdc4 tumor suppressor in human cancer. Tan Y; Sangfelt O; Spruck C Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364 [TBL] [Abstract][Full Text] [Related]
9. Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint. Bailey ML; Singh T; Mero P; Moffat J; Hieter P Genetics; 2015 Nov; 201(3):885-95. PubMed ID: 26354767 [TBL] [Abstract][Full Text] [Related]
10. FBXW7 and DNA copy number instability. Byrd KN; Huey B; Roydasgupta R; Fridlyand J; Snijders AM; Albertson DG Breast Cancer Res Treat; 2008 May; 109(1):47-54. PubMed ID: 17588203 [TBL] [Abstract][Full Text] [Related]
11. hCDC4 gene mutations in endometrial cancer. Spruck CH; Strohmaier H; Sangfelt O; Müller HM; Hubalek M; Müller-Holzner E; Marth C; Widschwendter M; Reed SI Cancer Res; 2002 Aug; 62(16):4535-9. PubMed ID: 12183400 [TBL] [Abstract][Full Text] [Related]
12. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias. Song JH; Schnittke N; Zaat A; Walsh CS; Miller CW Leuk Res; 2008 Nov; 32(11):1751-5. PubMed ID: 18485478 [TBL] [Abstract][Full Text] [Related]
13. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. van Drogen F; Sangfelt O; Malyukova A; Matskova L; Yeh E; Means AR; Reed SI Mol Cell; 2006 Jul; 23(1):37-48. PubMed ID: 16818231 [TBL] [Abstract][Full Text] [Related]
14. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001 [TBL] [Abstract][Full Text] [Related]
15. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Yu JC; Ding SL; Chang CH; Kuo SH; Chen ST; Hsu GC; Hsu HM; Hou MF; Jung LY; Cheng CW; Wu PE; Shen CY Carcinogenesis; 2009 Sep; 30(9):1562-70. PubMed ID: 19587092 [TBL] [Abstract][Full Text] [Related]
16. hCDC4 gene mutation is rare in colorectal carcinomas in Korean patients. Lee JW; Jeong EG; Lee SH; Yoo NJ; Lee SH Pathology; 2008 Apr; 40(3):305. PubMed ID: 18428053 [No Abstract] [Full Text] [Related]
17. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability. Kemp Z; Rowan A; Chambers W; Wortham N; Halford S; Sieber O; Mortensen N; von Herbay A; Gunther T; Ilyas M; Tomlinson I Cancer Res; 2005 Dec; 65(24):11361-6. PubMed ID: 16357143 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer. Akhoondi S; Lindström L; Widschwendter M; Corcoran M; Bergh J; Spruck C; Grandér D; Sangfelt O Breast Cancer Res; 2010; 12(6):R105. PubMed ID: 21122106 [TBL] [Abstract][Full Text] [Related]
19. hCDC4 and genetic instability in cancer. Rajagopalan H; Lengauer C Cell Cycle; 2004 Jun; 3(6):693-4. PubMed ID: 15118416 [TBL] [Abstract][Full Text] [Related]
20. Low frequency of hCDC4 mutations in human primary ovarian cancer. Sgambato A; Cittadini A; Masciullo V; Di Salvatore M; Graziani C; Rettino A; Valdivieso P; Scambia G; Bianchino G; Zupa A; Improta G; Cifarelli RA Gynecol Oncol; 2007 May; 105(2):553-5. PubMed ID: 17320938 [No Abstract] [Full Text] [Related] [Next] [New Search]